MRI引导局灶挽救性高剂量率近距离治疗放射性复发前列腺癌后生化失败的多变量预测模型开发与内部验证
本研究基于150例接受MRI引导局灶挽救性高剂量率近距离治疗(FS-HDR-BT)的放射性复发前列腺癌患者的前瞻性队列,开发并内部验证了两个预测生化失败(BF,Phoenix定义)的多变量Cox模型。模型1仅纳入挽救前变量,模型2额外纳入挽救后特征,调整后C统计量分别为0.73和0.84,校准可接受。两模型均可识别BF高危患者,有助于治疗咨询。
要点
- 模型1(挽救前变量)预测BF的C统计量为0.73,模型2(含挽救后特征)为0.84。
- 低、中、高危组2年生化无病生存率:模型1为84%、70%、31%;模型2为100%、71%、5%。
- 挽救前年龄、肿瘤总体积、PSA及PSA倍增时间可预测BF。
核心结论
- 两个模型可用于预测放射性复发前列腺癌患者接受FS-HDR-BT后的生化失败,并识别高危患者以辅助咨询。
研究设计与样本
- 前瞻性队列研究,纳入2013至2020年间150例接受FS-HDR-BT的放射性复发前列腺癌患者,用于模型开发与内部验证。
- 采用多变量Cox比例风险回归构建模型,模型1仅含挽救前变量,模型2额外测试挽救后特征,经校准后构建列线图和网络工具并划分三个风险组。
主要发现
- 模型1中,年龄、肿瘤总体积、挽救前PSA和挽救前PSA倍增时间(PSADT)预测BF。
- 模型2中,年龄、挽救前PSA和PSADT、精囊腺侵犯、挽救后至PSA最低点时间及PSA下降百分比预测BF。
- 模型1和模型2的调整C统计量分别为0.73(95%CI:0.66-0.81)和0.84(95%CI:0.78-0.90),校准可接受。
- 低、中、高危组估计2年生化无病生存率:模型1为84%、70%、31%;模型2为100%、71%、5%。
临床怎么用
- 可利用基于挽救前变量的模型1在FS-HDR-BT前进行患者咨询和风险分层。
- 可利用纳入挽救后特征的模型2在随访中动态评估生化失败风险,识别高危患者。
局限性
- 研究为单中心前瞻性队列的内部验证,未进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Magnetic resonance-guided focal salvage high-dose-rate brachytherapy (FS-HDR-BT) for radiorecurrent prostate cancer (PCa) shows low toxicity rates. However, biochemical failure (BF) after treatment occurs frequently. We developed two prediction models for BF (Phoenix definition) with the aim of enhancing patient counselling before FS-HDR-BT and during follow-up. MATERIALS AND METHODS: A prospective cohort of 150 radiorecurrent PCa patients treated with FS-HDR-BT between 2013 and 2020 was used for model development and internal validation. Multivariable Cox Proportional Hazards regression was applied. For model 1, only pre-salvage variables were included as candidate predictors. For model 2, additional (post-)salvage characteristics were tested. After calibration, nomograms and webtools were constructed. Finally, three risk groups were identified. RESULTS: Sixty-one patients (41%) experienced BF. At baseline (model 1), age, gross tumour volume, pre-salvage PSA, and pre-salvage PSA doubling time (PSADT) were predictive of BF. During follow-up (model 2), age, pre-salvage PSA and PSADT, seminal vesicle involvement, post-salvage time to PSA nadir, and percentage PSA reduction were predictive of BF. The adjusted C-statistics were 0.73 (95% CI: 0.66-0.81) and 0.84 (95% CI: 0.78-0.90), respectively, with acceptable calibration. Estimated 2-year biochemical disease-free survival for the low-, intermediate-, and high-risk groups were 84%, 70%, and 31% (model 1), and 100%, 71%, and 5% (model 2). CONCLUSION: Two models are provided for prediction of BF in patients with radiorecurrent PCa treated with FS-HDR-BT. Based on pre- and post-salvage characteristics, we are able to identify patients with a high risk of BF. These findings can aid patient counselling for FS-HDR-BT.
引用
- Willigenburg T, van Son MJ, van de Pol SMG, et al. Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer. Clin Transl Radiat Oncol. 2021. PMID: 34278009. doi:10.1016/j.ctro.2021.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。